New York S 1917: Establishes an emergency insulin program
Status: REPORTED AND COMMITTED TO FINANCE (as of 2026-05-05)
State: New York · Session: 2025-2026 · Bill: S 1917
Sponsors: Gustavo Rivera, Andrew Gounardes, Liz Krueger, Luis R. Sepúlveda, Roxanne J. Persaud, Samra Brouk, Zellnor Myrie
Bill Text
Bill Search and Legislative Information | New York State Assembly • • • • • • • • Skip to main content New York State Assembly Speaker Carl E. Heastie --> --> --> • Assembly Members • Legislative Info • Public Hearings • Speaker's Press • Assembly Reports • Committees & More • Bill Search Home • Laws • Legislative Calendar • Public Hearing Schedule • Assembly Calendars • Assembly Committee Agenda Javascript must be enabled to properly view this page. Bill No.: • Summary • Actions • Committee Votes • Floor Votes • Memo • Text • LFIN • Chamber Video/Transcript S01917 Summary: BILL NOS01917A   SAME ASNo Same As   SPONSORRIVERA   COSPNSRBROUK, GOUNARDES, KRUEGER, MYRIE, PERSAUD, SEPULVEDA   MLTSPNSR   Add Art 28-CC §2894, Pub Health L; add §95-l, St Fin L   Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins. Go to top S01917 Actions: BILL NOS01917A   01/14/2025REFERRED TO HEALTH 01/07/2026REFERRED TO HEALTH 04/21/2026AMEND AND RECOMMIT TO HEALTH 04/21/2026PRINT NUMBER 1917A 05/05/2026REPORTED AND COMMITTED TO FINANCE Go to topS01917 Committee Votes: Go to topS01917 Floor Votes: There are no Assembly votes for this bill in this legislative session. Go to topS01917 Text: STATE OF NEW YORK ________________________________________________________________________ 1917--A 2025-2026 Regular Sessions IN SENATE January 14, 2025 ___________ Introduced by Sens. RIVERA, BROUK, GOUNARDES, KRUEGER, MYRIE, PERSAUD, SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law and the state finance law, in relation to an emergency insulin program The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new article 2 28-CC to read as follows: 3 ARTICLE 28-CC 4 EMERGENCY INSULIN PROGRAM 5 Section 2894. Emergency insulin program. 6 § 2894. Emergency insulin program. 1. The commissioner is authorized 7 and directed to establish an emergency insulin program to ensure that 8 recipients of the program can access emergency supplies of analog insu- 9 lins and related supplies. The commissioner shall immediately engage 10 analog insulin manufacturers to support the state program and facilitate 11 quick access to affordable analog insulins in emergency situations. The 12 commissioner shall establish standards for approval of any emergency 13 insulin program, and analog insulin prescribing, dispensing, distrib- 14 ution, and possession pursuant to this section which may include, but 15 not be limited to, standards for program directors, appropriate clinical 16 oversight, training, record keeping and reporting. The emergency insulin 17 program shall, pursuant to an appropriation or sufficient funds in the 18 emergency insulin program trust fund, be available to recipients no 19 later than April first, two thousand twenty-seven. 20 2. (a) As used in this section: EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03543-02-6 S. 1917--A 2 1 (i) "Analog insulins" means at a minimum short-acting, rapid-acting, 2 intermediate and long acting insulin drugs approved by the Food and Drug 3 Administration that, when administered, to certain recipients are life- 4 saving, and help avoid serious adverse effects associated with type one 5 diabetes and in some limited cases type two diabetes, and other medica- 6 tions and supplies approved by the department for such purpose. 7 (ii) "Health care professional" means a person licensed, registered or 8 authorized pursuant to title eight of the education law to prescribe 9 prescription drugs. 10 (iii) "Pharmacist" means a person licensed or authorized to practice 11 pharmacy pursuant to article one hundred thirty-seven of the education 12 law. 13 (iv) "Recipient" means a person: (1) diagnosed with type one diabetes, 14 or type two insulin dependent diabetes; and (2) who is at risk of expe- 15 riencing serious adverse health effects due to a lack of analog insu- 16 lins; and (3) who is uninsured or underinsured; or (4) an organization 17 registered as an emergency insulin program pursuant to this section. 18 (b)(i) A health care professional may prescribe by a patient-specific 19 or non-patient-specific prescription, dispense or distribute, directly 20 or indirectly, analog insulins to a recipient. 21 (ii) A pharmacist may dispense analog insulins, through a patient-spe- 22 cific
View New York S 1917 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.